Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune-inflammatory and hypothalamic-pituitary-adrenal axis biomarkers are altered in patients with non-specific low back pain: A systematic review.
Sanabria-Mazo JP, Colomer-Carbonell A, Carmona-Cervelló M, Feliu-Soler A, Borràs X, Grasa M, Esteve M, Maes M, Edo S, Sanz A, Luciano JV. Sanabria-Mazo JP, et al. Among authors: borras x. Front Immunol. 2022 Sep 2;13:945513. doi: 10.3389/fimmu.2022.945513. eCollection 2022. Front Immunol. 2022. PMID: 36119028 Free PMC article.
Machine Learning to Understand the Immune-Inflammatory Pathways in Fibromyalgia.
Andrés-Rodríguez L, Borràs X, Feliu-Soler A, Pérez-Aranda A, Rozadilla-Sacanell A, Arranz B, Montero-Marin J, García-Campayo J, Angarita-Osorio N, Maes M, Luciano JV. Andrés-Rodríguez L, et al. Among authors: borras x. Int J Mol Sci. 2019 Aug 29;20(17):4231. doi: 10.3390/ijms20174231. Int J Mol Sci. 2019. PMID: 31470635 Free PMC article.
Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study).
Sanabria-Mazo JP, Forero CG, Cristobal-Narváez P, Suso-Ribera C, García-Palacios A, Colomer-Carbonell A, Pérez-Aranda A, Andrés-Rodríguez L, McCracken LM, D'Amico F, Estivill-Rodríguez P, Carreras-Marcos B, Montes-Pérez A, Comps-Vicente O, Esteve M, Grasa M, Rosa A, Cuesta-Vargas AI, Maes M, Borràs X, Edo S, Sanz A, Feliu-Soler A, Castaño-Asins JR, Luciano JV. Sanabria-Mazo JP, et al. Among authors: borras x. BMJ Open. 2020 Jul 23;10(7):e038107. doi: 10.1136/bmjopen-2020-038107. BMJ Open. 2020. PMID: 32709656 Free PMC article.
Mindfulness-Based Program Plus Amygdala and Insula Retraining (MAIR) for the Treatment of Women with Fibromyalgia: A Pilot Randomized Controlled Trial.
Sanabria-Mazo JP, Montero-Marin J, Feliu-Soler A, Gasión V, Navarro-Gil M, Morillo-Sarto H, Colomer-Carbonell A, Borràs X, Tops M, Luciano JV, García-Campayo J. Sanabria-Mazo JP, et al. Among authors: borras x. J Clin Med. 2020 Oct 11;9(10):3246. doi: 10.3390/jcm9103246. J Clin Med. 2020. PMID: 33050630 Free PMC article.
Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study).
Colomer-Carbonell A, Sanabria-Mazo JP, Hernández-Negrín H, Borràs X, Suso-Ribera C, García-Palacios A, Muchart J, Munuera J, D'Amico F, Maes M, Younger JW, Feliu-Soler A, Rozadilla-Sacanell A, Luciano JV. Colomer-Carbonell A, et al. Among authors: borras x. BMJ Open. 2022 Jan 6;12(1):e055351. doi: 10.1136/bmjopen-2021-055351. BMJ Open. 2022. PMID: 34992118 Free PMC article.
Immune-inflammatory pathways and clinical changes in fibromyalgia patients treated with Mindfulness-Based Stress Reduction (MBSR): A randomized, controlled clinical trial.
Andrés-Rodríguez L, Borràs X, Feliu-Soler A, Pérez-Aranda A, Rozadilla-Sacanell A, Montero-Marin J, Maes M, Luciano JV. Andrés-Rodríguez L, et al. Among authors: borras x. Brain Behav Immun. 2019 Aug;80:109-119. doi: 10.1016/j.bbi.2019.02.030. Epub 2019 Feb 25. Brain Behav Immun. 2019. PMID: 30818032 Clinical Trial.
Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression.
Andrés-Rodríguez L, Borràs X, Feliu-Soler A, Pérez-Aranda A, Angarita-Osorio N, Moreno-Peral P, Montero-Marin J, García-Campayo J, Carvalho AF, Maes M, Luciano JV. Andrés-Rodríguez L, et al. Among authors: borras x. Brain Behav Immun. 2020 Jul;87:881-889. doi: 10.1016/j.bbi.2019.12.020. Epub 2019 Dec 27. Brain Behav Immun. 2020. PMID: 31887417 Review.
Psychometric Properties of the Cognitive Emotion Regulation Questionnaire (CERQ) in Patients with Fibromyalgia Syndrome.
Feliu-Soler A, Reche-Camba E, Borràs X, Pérez-Aranda A, Andrés-Rodríguez L, Peñarrubia-María MT, Navarro-Gil M, García-Campayo J, Bellón JA, Luciano JV. Feliu-Soler A, et al. Among authors: borras x. Front Psychol. 2017 Dec 13;8:2075. doi: 10.3389/fpsyg.2017.02075. eCollection 2017. Front Psychol. 2017. PMID: 29321750 Free PMC article.
Patients With Fibromyalgia Reporting Severe Pain but Low Impact of the Syndrome: Clinical and Pain-Related Cognitive Features.
Angarita-Osorio N, Pérez-Aranda A, Feliu-Soler A, Andrés-Rodríguez L, Borràs X, Suso-Ribera C, Slim M, Herrera-Mercadal P, Fernández-Vergel R, Blanco ME, Luciano JV. Angarita-Osorio N, et al. Among authors: borras x. Pain Pract. 2020 Mar;20(3):255-261. doi: 10.1111/papr.12847. Epub 2019 Nov 11. Pain Pract. 2020. PMID: 31627253
90 results